StockGuru Blog: RxElite (SOUT) – SEVOFLURANE SALES CONTINUE TO DOUBLE MONTH TO MONTH
Stock Guru Profile News Blogs Oppenheimer’s October report states that in October Sevoflurane (known as Sojourn for Minrad) sales continue to DOUBLE MONTH TO MONTH: Summary: We recently spoke with senior management from both Minrad and RxElite (Sojourn distributor). We remain confident that the long-term outlook for BUF remains positive, although near-term financials could remain noisy. Importantly, the key levers remain on track, including: 1) plant expansion should be complete in Q407, and 2) Rx Elite remains on track to hit first year minimums. (SOUT, Not Covered) imply that Sojourn continues to roll out on-track to hit the first year…
